Results 281 to 290 of about 521,894 (411)

Correction to: Inhibition of USP30 Promotes Mitophagy by Regulating Ubiquitination of MFN2 by Parkin to Attenuate Early Brain Injury After SAH. [PDF]

open access: yesTransl Stroke Res
Liu Y   +13 more
europepmc   +1 more source

Antiseizure medication choice in diffuse glioma: A single‐center population‐based experience

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Several antiseizure medications (ASMs) can be considered as first‐line treatment for glioma‐associated epilepsy (GAE). We aimed to find out, if there are subgroups of glioma patients which may benefit from different first‐line ASMs. Methods All diffuse glioma (grade 2–4) patients, who were in contact with Helsinki University Hospital
Leena Ollila, Reina Roivainen
wiley   +1 more source

The role of artificial intelligence in diagnostic neurosurgery: a systematic review. [PDF]

open access: yesNeurosurg Rev
Li W   +5 more
europepmc   +1 more source

Glioblastoma multiforme with transdural extension to the external auditory canal via the tegmen tympani—Clinical report with review of the literature

open access: yes
Eye &ENT Research, EarlyView.
Arba Cecia   +6 more
wiley   +1 more source

Phenotype and surgical management of drug‐resistant epilepsy in patients with COL4A1 and COL4A2 variants

open access: yesEpilepsia Open, EarlyView.
Abstract Objective To summarize the clinical features of collagen type IV alpha 1/2 chain (COL4A)1/2‐related epilepsy and the seizure outcomes of patients undergoing epilepsy surgery. Methods We retrospectively analyzed the clinical, electroencephalography, and neuroimaging data; genetic characteristics; surgical details; and prognosis of 8 patients (4
Jie Shi   +12 more
wiley   +1 more source

Real‐world effectiveness and tolerability of cenobamate in drug‐resistant epilepsy: A retrospective analysis of the patients included into the Early Access Programs (EAP) in Germany, France, and United Kingdom

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Investigate real‐world outcomes in drug‐resistant epilepsy (DRE) patients treated with cenobamate as adjunctive treatment to other antiseizure medications (ASMs) within the Early Access Programs (EAP) in Germany, France, and the United Kingdom.
Sylvain Rheims   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy